This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $11,294.90 firm fixed price delivery order is for the supply of 4,565,586,342 tablets of the medication Dapagliflozin 5 mg. The award does not have a set-aside designation. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen Drug Corporation is a major pharmaceutical distributor that provides a...
This federal contract award, valued at $33,415.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4,565,617,733 units of the prescription drug Dapagliflozin 10 mg tablet. The contract has an ultimate completion date of August 29, 2024, and is a firm fixed-price delivery order. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S. The $6,097.92 firm fixed-price contract has a completion date of March 18, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $6,450.70 and issued by the Defense Logistics Agency (DLA). The contract is for the delivery of the pharmaceutical product Dapagliflozin 5 mg Tablet, a medication used to treat type 2 diabetes. The order has a firm fixed-price pricing type and an ultimate completion date of September 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,918.93 firm-fixed-price delivery order is for the supply of 4,567,012,423 tablets of the medication dapagliflozin 10 mg. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,351.80 firm-fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a prescription medication. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,477.55 firm fixed-price delivery order covers the supply of 4,564,802,316 units of the medication dapagliflozin 5 mg tablets. The contract has an ultimate completion date of June 5, 2024 and was awarded on June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,772.53, is for the delivery of dapagliflozin 10 mg tablets. This is a Firm Fixed Price Delivery Order contract with a period of performance through January 31, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,041.36 fixed-price delivery order is for the supply of 4,565,634,033 tablets of the prescription drug Dapagliflozin 10 mg. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as several other Indefinite Delivery Contracts (IDCs) with the DLA and...